Due to the current Public Health Crisis, we are operating with limited staffing and will be focusing on helping patients through the hotline. Because hotline services are restricted to patients, for the time being, we kindly ask pharmacies, providers, and their staff to use our Pharmacy and Provider Portals during this time. If you have a question that cannot be answered by visiting the portal, please send an email to grants@healthwellfoundation.org. We appreciate your patience and look forward to continuing to serve you.

Dismiss alert

HealthWell Access to Care Research
Grant Call for Proposals

This program will support health systems, behavioral science, or health economics research focused on the problem of access to care. Research should address one of the key issues involved in facilitating access to care for the underinsured, including cost of care, financial need and financial impact of illness, health consequences of access or lack of access, attitudes and experience among patients, family, or providers, adherence and compliance issues, as well as other issues related to access to care.

The HealthWell Foundation is a 501(c)(3) independent, non-profit organization that provides financial assistance to underinsured patients living with chronic or life-threatening diseases such as cancer, asthma, and autoimmune disorders. The Foundation helps eligible individuals afford their out-of-pocket costs for prescription drug copayments, coinsurance, deductibles, premiums, and other selected out-of-pocket costs. For more information, visit the HealthWell Foundation website at www.healthwellfoundation.org.

The awards will be for up to $150,000 in total costs over 2 years ($75,000/year) to support the research proposal and the investigators time and effort. It is expected that 2 grants will be awarded in 2019.

Any academic researcher at a university or non-profit research institute in the U.S. at the time of application is eligible. No more than 15% of the funding can go to indirect costs (included in total costs).


  1. Cover page with name, institution, contact information, and project title.
  2. Initial proposal should be 2 pages (1,000 words or less) and should include a description of proposed research (including background, aims, and methods), experience of the research team, and impact.
  3. 5 page Biosketch, NIH format including personal statement, of Principal investigator.

Process and Requirements:
Initial proposals must be submitted electronically to research@healthwellfoundation.org by close of business May 1st, 2019. Select applicants will then be selected to submit a full proposal by July 1st, 2019 (including rationale, aims, background, significance, methodology, and analytic approach, limited to 6 pages, plus a proposed budget, budget justification, and timeline for research). Awardees will be required to submit a progress report every 6 months including a final report at the end of the funding period. Awardees will be invited to a HealthWell Board meeting and dinner to present their research.

To submit a proposal, please address all correspondence and questions electronically to: research@healthwellfoundation.org.

Research Advisory Panel

  • 1.Suzanne M. Miller, PhD, Board Member

    Dr. Suzanne Miller  is Professor and Director of the Patient Empowerment and Decision-Making Department, as well as a member of the Cancer Prevention and Control Program, at Fox Chase Cancer Center/Temple University Health System. She is also an Adjunct Professor at Temple University, Lewis Katz School of Medicine (Department of Obstetrics, Gynecology, and Reproductive Medicine) and Temple University, College of Health Professions. Her funded research and clinical services are focused at the interface of psychology and oncology, particularly with a view to applying personalized biobehavioral and health communication principles to bridge the gap between the availability of groundbreaking cancer prevention and control technologies and the populations they are meant to serve. Her most recent books are Individuals, Families, and the New Era of Genomics: Biopsychosocial Perspectives (Norton Publications, 2006), The Handbook of Cancer Control and Behavioral Science: A Resource for Researchers, Practitioners, and Policy Makers (APA Publications, 2008), and The Handbook of Health Decision Science (Springer Publications, 2016).

    Dr. Miller is the Chair of the New Jersey Health Care Quality Institute board and is a member of numerous other non-profit and academic boards, including the Society of Behavioral Medicine (SBM). She is the Editor-in-Chief of SBM’s flagship journal, Translational Behavioral Medicine: Practice, Policy, Research. Dr. Miller is a fellow of the American Psychological Association and the Society of Behavioral Medicine. She was awarded the Partners in Research Award from the National Cancer Institute’s Cancer Information Service, the Cancer Control Award from the American Cancer Society, the Outstanding Senior Scientist Oncology Award from the Society of Behavioral Medicine, The C. Tracey Orleans Award for Outstanding Service to the Society of Behavioral Medicine, and, most recently, NCI’s featured grantee. She speaks and writes about the effects of cancer on the American population and how to live an informed and healthy life from a multicultural perspective. With respect to her international acclaim, her concepts and measures have been translated into numerous cultures and languages, with health disparities and health literacy as a prime focus. She has served as an invited distinguished visiting professor in Japan, Italy, Switzerland, China, the Netherlands, France, Israel, Australia and Poland, among others, and maintains collaborative cross-cultural linkages.

  • 2.Jeffrey Peppercorn, MD, MPH, Scientific and Ethics Advisor

    Jeffrey Peppercorn, MD, MPH is a medical oncologist specializing in breast cancer and Director of the Massachusetts General Hospital Supportive Care and Survivorship Program.  He is an Associate Professor of Medicine at Harvard Medical School.  His research interests include bioethics and policy issues related to cancer care.  He is also engaged in clinical and health services research aimed at improving care delivery and outcomes for cancer survivors. He chairs the Ethics committee of the Alliance for Clinical Trials in Oncology and has served as Chair of the Ethics committee of the American Society for Clinical Oncology (ASCO) and on the NCCN guidelines panel for cancer survivors.  His research has been funded by the NIH, American Cancer Society, Greenwall Foundation for Bioethics, National Comprehensive Cancer Network, and ASCO and he has published over 125 papers related to oncology and bioethics.  He has served as an advisor to the Healthwell Foundation for many years and currently serves as the Scientific and Ethics Advisor to the foundation.